Marker Therapeutics Provides Updates of its Lead Clinical Programs
Go back to Marker Therapeutics Provides Updates of its Lead Clinical Programs| (NASDAQ: MRKR) | Delayed: 1.20 -0.01 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $ | |||
| Open | $1.21 | 52 Week Low | $ | |||
| Day High | $1.23 | P/E | N/A | |||
| Day Low | $1.18 | EPS | $ | |||
| Volume | 55,517 | |||||
